Translational Oncology: From Molecular Basis to Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 20 August 2025 | Viewed by 518
Special Issue Editors
Interests: translational oncology; resistance to therapy; secretome signaling; microRNAs; cell transformation; tumor microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of Translational Oncology is rapidly expanding owing to the increasing availability of molecular targets in tumors and targeted compounds. With the merging of multi-omics, including genomics, proteomics, metabolomics, and glycomics, we are gaining a deeper understanding of the adaptive dynamics of tumors, beyond what single genomics can offer. Additionally, novel models such as 3D growing spheroids, organoids, and microfluidic-based cultures are now available, and these are of higher clinical relevance. It is crucial that we obtain a comprehensive understanding of tumor biology that encompasses all of these aspects to fully comprehend the complexity of cancer. This understanding is of the upmost priority and promises to provide novel tools that attenuate cancer progression and resistance to therapy. We kindly invite you to join us in discussing all of these important aspects of this topic.
Dr. Mario Cioce
Dr. Gatti Veronica
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- therapy resistance
- translational oncology
- cancer stem cells
- immunotherapy
- cancer metabolism
- OMICS
- patient-derived-organoids
- drug repositioning
- TKI
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
